The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.

Bisphosphonates are effective in the management of bone disease in patients with multiple myeloma and recent reports have suggested that they may also have an anti-tumour activity. In support of this, we have previously demonstrated that bisphosphonates can induce myeloma cell apoptosis in vitro; ho...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Shipman, C, Vanderkerken, K, Rogers, M, Lippitt, J, Asosingh, K, Hughes, D, Van Camp, B, Russell, R, Croucher, P
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2000

Những quyển sách tương tự

Bisphosphonates--mechanisms of action in multiple myeloma.
Bằng: Shipman, C, et al.
Được phát hành: (2000)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Bằng: Croucher, P, et al.
Được phát hành: (2003)

Bisphosphonates and in vivo models of multiple myeloma - Reply
Bằng: Shipman, C, et al.
Được phát hành: (2001)

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
Bằng: Vanderkerken, K, et al.
Được phát hành: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Bằng: Croucher, P, et al.
Được phát hành: (2001)

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
Bằng: Shipman, C, et al.
Được phát hành: (1997)

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Bằng: Shipman, C, et al.
Được phát hành: (1998)

Anti-tumour activity of bisphosphonates in human myeloma cells.
Bằng: Shipman, C, et al.
Được phát hành: (1998)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2000)

Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2001)

Osteoprotegerin and the development of myeloma bone disease
Bằng: Croucher, P, et al.
Được phát hành: (2004)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
Bằng: Croucher, P, et al.
Được phát hành: (2002)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2001)

Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma
Bằng: Croucher, P, et al.
Được phát hành: (2002)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
Bằng: Shipman, C, et al.
Được phát hành: (2000)

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma
Bằng: Mueller, G, et al.
Được phát hành: (2004)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
Bằng: Shipman, C, et al.
Được phát hành: (2002)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
Bằng: Mueller, G, et al.
Được phát hành: (2004)

Zoledronic acid prevents the development of myeloma bone disease and increases survival
Bằng: Shipman, C, et al.
Được phát hành: (2002)

Nitrogen-containing bisphosphonates induce apoptosis in human bone marrow-derived myeloma cells in vitro by inhibiting protein prenylation.
Bằng: Gordon, S, et al.
Được phát hành: (1999)

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Bằng: Edwards, C, et al.
Được phát hành: (2007)

Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
Bằng: De Leenheer, E, et al.
Được phát hành: (2004)

Tumour cells isolated from patients with multiple myeloma express the critical osteoclastogenic factor, RANKL.
Bằng: Shipman, C, et al.
Được phát hành: (2000)

Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.
Bằng: De Leenheer, E, et al.
Được phát hành: (2002)

Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors.
Bằng: Locklin, R, et al.
Được phát hành: (2005)

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
Bằng: Croucher, P, et al.
Được phát hành: (2003)

The bisphosphonate-ester apornine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells
Bằng: Roelofs, A, et al.
Được phát hành: (2006)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
Bằng: Richard Derman, et al.
Được phát hành: (2009-09-01)

Osteoblasts protect multiple myeloma cells from T-cell-induced apoptosis
Bằng: Locklin, R, et al.
Được phát hành: (2007)

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
Bằng: Liesbeth Bieghs, et al.
Được phát hành: (2010-01-01)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
Bằng: Shipman, C, et al.
Được phát hành: (2002)

The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
Bằng: Nutrisia Aquariushinta Sayuti, et al.
Được phát hành: (2020-09-01)

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
Bằng: Shipman, C, et al.
Được phát hành: (2003)

Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment
Bằng: V Venkataramana, et al.
Được phát hành: (2014-01-01)

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
Bằng: Jagdev, S, et al.
Được phát hành: (2001)

Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.
Bằng: Clive Henry Buckle, et al.
Được phát hành: (2012-01-01)

NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro
Bằng: Roelofs, A, et al.
Được phát hành: (2004)

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
Bằng: Locklin, R, et al.
Được phát hành: (2007)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
Bằng: Maria Nieves Lopez Muñoz, et al.
Được phát hành: (2023-08-01)

The pharmacology of bisphosphonates and new insights into their mechanisms of action.
Bằng: Russell, R, et al.
Được phát hành: (1999)